Aurobindo Pharma today said it may launch Tramadol Hydrochloride extended-release tablets, used for treating pain, in the US market from January. According to a statement issue by the company, it has ...

According to a statement issue by the company, it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market the drug. The state's drug controller suspended the ...

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated October 23, 2015 titled "Aurobindo Pharma receives USFDA Approval for Tramadol Hydrochloride Extended-release Tablets".Source : ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...

Aurobindo Pharma on Friday said it may launch Tramadol Hydrochloride extended-release tablets, used for treating pain, in the US market from January. According to a statement issue by the company, it ...

Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, ...

Aurobindo Pharma received final approval from the USFDA to manufacture and market the drug. Photo: Bloomberg Hyderabad: Aurobindo Pharma on Friday said it may launch Tramadol Hydrochloride ...

Aurobindo Pharma surged over 6 per cent intraday on Thursday after it received tentative approval for Dolutegravir 50mg from US Food & Drug Administration (USFDA) used in the treatment of HIV-1 ...